REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q3 2013 13F Holders as of 30 Sep 2013
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 104,986,330
- Total 13F shares
- 1,458,057
- Share change
- +796,118
- Total reported value
- $456,100,415
- Price per share
- $312.87
- Number of holders
- 19
- Value change
- +$249,187,180
- Number of buys
- 10
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.37%
|
391,909
|
$88,133,000 | — | 30 Jun 2013 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0.06%
|
61,659
|
$13,866,000 | — | 30 Jun 2013 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.05%
|
54,565
|
$12,271,000 | — | 30 Jun 2013 | |
| Retirement Systems of Alabama |
13F
|
Company |
0.04%
|
44,929
|
$10,104,000 | — | 30 Jun 2013 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
24,152
|
$5,432,000 | — | 30 Jun 2013 | |
| HARTFORD INVESTMENT MANAGEMENT CO |
13F
|
Company |
0.02%
|
23,207
|
$5,219,000 | — | 30 Jun 2013 | |
| Asset Management One Co., Ltd. |
13F
|
Company |
0.01%
|
12,895
|
$3,016,000 | — | 30 Jun 2013 | |
| SECURIAN ASSET MANAGEMENT, INC |
13F
|
Company |
0.01%
|
6,730
|
$1,513,000 | — | 30 Jun 2013 | |
| Veritable, L.P. |
13F
|
Company |
0%
|
4,275
|
$961,000 | — | 30 Jun 2013 | |
| AZZAD ASSET MANAGEMENT INC /ADV |
13F
|
Company |
0%
|
2,908
|
$694,275 | — | 30 Jun 2013 | |
| Joel Isaacson & Co., LLC |
13F
|
Company |
0%
|
3,000
|
$675,000 | — | 30 Jun 2013 | |
| Partner Investment Management, L.P. |
13F
|
Company |
0%
|
1,871
|
$421,000 | — | 30 Jun 2013 | |
| RATIONAL ADVISORS, INC. |
13F
|
Company |
0%
|
1,850
|
$416,000 | — | 30 Jun 2013 | |
| E. Ohman J:or Asset Management AB |
13F
|
Company |
0%
|
1,600
|
$359,808 | — | 30 Jun 2013 | |
| Twin Tree Management, LP |
13F
|
Company |
0%
|
1,201
|
$270,000 | — | 30 Jun 2013 | |
| HUNTINGTON NATIONAL BANK |
13F
|
Company |
0%
|
116
|
$26,000 | — | 30 Jun 2013 | |
| First Horizon Advisors, Inc. |
13F
|
Company |
0%
|
18
|
$4,000 | — | 30 Jun 2013 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q3 2013
As of 30 Sep 2013,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,458,057 shares.
The largest 10 holders included
WELLS FARGO & COMPANY/MN, Citadel Advisors LLC, Partner Fund Management, L.P., Retirement Systems of Alabama, Zurcher Kantonalbank (Zurich Cantonalbank), HARTFORD INVESTMENT MANAGEMENT CO, Partner Investment Management, L.P., PDT Partners, LLC, State of Tennessee, Treasury Department, and DIAM Co., Ltd..
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2013 vs Q2 2013 Across Filers
Q2 2013 holders
17
Q3 2013 holders
19
Holder diff
2
| Investor | Q2 2013 Shares | Q3 2013 Shares | Share Diff | Share Chg % | Q2 2013 Value $ | Q3 2013 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.